866-997-4948(US-Canada Toll Free)

Onychomycosis Treatment Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028

Published By :

Future Market Insights

Published Date : Jan 2019

Category :

Therapeutic Area

No. of Pages : 323 Pages

A recent market study published by FMI – 'Onychomycosis Treatment Market: Global Industry Analysis 2013-2017 & Opportunity Assessment 2018-2028', consists of a comprehensive assessment of the most important market dynamics. On conducting a thorough research on the historic as well as current growth parameters of the onychomycosis treatment market, growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may have a huge impact on the development of the onychomycosis treatment market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in the onychomycosis treatment market in the coming years. The report provides detailed information about the current and future growth prospects of the onychomycosis treatment market in the most comprehensive way for the better understanding of the readers.

Chapter 1 – Executive Summary

The report commences with the executive summary of the onychomycosis treatment market, which includes the summary of the key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments in the onychomycosis treatment market.

Chapter 2 – Market Introduction

Readers can find a detailed taxonomy and the definition of the onychomycosis treatment market in this chapter, which helps them understand the basic information about onychomycosis treatment. This section also highlights the inclusions and exclusions, which helps readers understand the scope of the report.

Chapter 3 – Market Opportunity Analysis

This chapter explains the key macro-economic factors that are influencing the growth of the onychomycosis treatment market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis for the onychomycosis treatment market. This chapter helps readers understand the market opportunity that provides them leverage to plan their strategy accordingly.

Chapter 4 – Market Background

This chapter highlights the key market dynamics, including the drivers, restraints, and trends. Both, supply-side drivers and demand-side drivers of the onychomycosis treatment market are explained well in this chapter. Readers can understand the factors that are propelling the growth of the onychomycosis treatment market, along with factors that may deter the growth of the market. Readers will also understand the key trends followed by leading manufacturers in the onychomycosis treatment market.

Chapter 5 – Key Inclusions

This chapter highlights key inclusions of the report such as key regulations, reimbursement scenario, and pipeline assessment. Parent market analysis helps readers understand the share of the global onychomycosis treatment market in the overall dermatology market. The key regulations section of this chapter highlights the FDA and EMA regulatory process for the approval of drugs. The reimbursement scenario provides CPT codes used for onychomycosis treatment. Also, the detailed explanation about each CPT code is mentioned in this section. The pipeline assessment includes a list of clinical trials going on for onychomycosis treatment around the world.

Chapter 6 – Global Economic Outlook

This section highlights the expenditure on health by the top countries in each region. It also explains the global and regional healthcare market outlook. The regional healthcare market focuses to explain deeply about the political, economic and business environment outlook of the respective region.

Chapter 7 – North America Onychomycosis Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028

This chapter includes detailed analysis of the growth of the North America onychomycosis treatment market, along with a country-wise assessment, including the U.S. and Canada. Readers can also find the key takeaways of this region, and market growth based on treatment type, indication, gender, age group, end user, and country of the onychomycosis treatment market in the North American region.

Chapter 8 – Latin America Onychomycosis Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028

Readers can find a snapshot of the Latin America onychomycosis treatment market in this chapter. This chapter includes the growth prospects of the onychomycosis treatment market in leading LATAM countries such as Brazil, Mexico, and the rest of the Latin American region.

Chapter 9 – Western Europe Onychomycosis Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028

Important growth prospects of the onychomycosis treatment market based on its treatment type, indication, gender, age group, and end user in several European countries such as the U.K., Germany, France, Italy, Spain, and the rest of the Western Europe are included in this chapter.

Chapter 10 – Eastern Europe Onychomycosis Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028

This chapter highlights the market growth of the onychomycosis treatment market in Eastern Europe by focusing on Russia and Poland. This section also helps readers understand the key factors that are responsible for the growth of the onychomycosis treatment market in Eastern Europe.

Chapter 11 – APECJ Onychomycosis Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028

Australia and New Zealand, India, China, and ASEAN are the leading countries/regions in the APECJ region that are the prime subject of assessment to obtain the growth prospects of the APECJ onychomycosis treatment market, in this chapter. Readers can find thorough information about the growth parameters of the APEJ onychomycosis treatment market during the period 2018-2028.

Chapter 12 – Japan Onychomycosis Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028

Readers can find important factors that can have a huge impact on the growth of the onychomycosis treatment market in Japan, based on the market segmentation, during the forecast period. This chapter highlights the key factors that are impacting the growth of the Japan onychomycosis treatment market over the forecast period.

Chapter 13 – MEA Onychomycosis Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028

This chapter provides information on how the onychomycosis treatment market will grow in major countries in MEA region, such as GCC Countries and South Africa, during the period 2018-2028.

Chapter 14 – Forecast Factors – Relevance and Impact

This chapter highlights the key factors taken into consideration while forecasting market value for the global onychomycosis treatment market. The impact of these forecast factors in different regions is also mentioned in this chapter.

Chapter 15 – Forecast Assumptions

This section helps readers understand the assumptions taken into account while estimating and forecasting the market size of onychomycosis treatment. The relative weightage of these assumptions are also mentioned in this section.

Chapter 16 – Market Structure Analysis

This section explains the tier structure of the global onychomycosis treatment market, which helps readers understand the percent share of market cover by tier 1, tier 2, and tier 3 players in this market. This section also explains company share analysis for the onychomycosis treatment market, which helps readers understand the market share taken by key players in the market.

Chapter 17 – Competition Landscape

In this chapter, readers can find a comprehensive list of all the leading manufacturers in the onychomycosis treatment market, along with detailed information about each company, including company overview, revenue share, strategic overview, recent company developments, and SWOT analysis. Market players featured in the report include Valeant Pharmaceuticals Inc., Galderma S.A., Novartis AG, Pfizer, Inc., Moberg Pharma AB, Johnson & Johnson Services, Inc., Bayer AG, Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Medimetriks Pharmaceuticals, Inc., Lumenis Ltd., Biofrontera AG, and Leo Pharma A/S.

Chapter 18 – Global Onychomycosis Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028 by Region

This chapter explains how the onychomycosis treatment market will grow across various geographic regions such as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan, and the Middle East & Africa (MEA).

Chapter 19 – Global Onychomycosis Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028 by Treatment Type

Based on treatment type, the onychomycosis treatment market is segmented into drugs, lasers, and photodynamic therapy. In this chapter, readers can find detailed analysis of the market by different treatment types and their growth over the forecast period.

Chapter 20 – Global Onychomycosis Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028 by Indication

Based on Indication, the onychomycosis treatment market is segmented into distal subungual onychomycosis, white superficial onychomycosis, proximal subungual onychomycosis, candidal onychomycosis, and total dystrophic onychomycosis. This section helps readers understand the different indications in the market over the forecast period.

Chapter 21 – Global Onychomycosis Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028 by Gender

Based on gender, the onychomycosis treatment market is segmented into male and female. This section helps readers analyze the prevalence of onychomycosis among both genders.

Chapter 22 – Global Onychomycosis Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028 by Age Group

Based on age group, the onychomycosis treatment market is segmented into 0-18 years, 18-39 years, 40-64 years, and 65 years and above. This section helps readers analyze the penetration of onychomycosis treatment among different age groups.

Chapter 23 – Global Onychomycosis Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028 by End User

Based on end user, the onychomycosis treatment market is segmented intoinstitutional sales and retail sales. In this chapter, readers can find information on market attractiveness analysis based on end users.

Chapter 24 – Global Onychomycosis Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028

This section explain the global market analysis and forecast for the onychomycosis treatment market. It also highlights the incremental opportunity for the onychomycosis market, along with absolute dollar opportunity for every year between the forecast period 2018-2028.

Chapter 25 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 26 – Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the onychomycosis treatment market.

Table of Content

1. Executive Summary

1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune

2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
2.3. Exclusion and Inclusion

3. Onychomycosis Treatment Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis

4. Market Background
4.1. Market Dynamics
4.1.1. Drivers
4.1.1.1. Supply Side Drivers
4.1.1.2. Demand Side Drivers
4.1.2. Restraints
4.2. Key Trends

5. Key Inclusions
5.1. Pipeline Assessment
5.2. Reimbursement Analysis
5.3. Regulatory Scenario

6. Global Economic Outlook
6.1. Gross Domestic Product by Region & Country, 2006 – 2021
6.2. Global Dermatology Market Outlook, 2017

7. North America Onychomycosis Treatment Market Analysis 2013–2017 and Forecast 2018–2028
7.1. Introduction
7.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
7.2.1. U.S.
7.2.2. Canada
7.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
7.4. Historical Market Size (US$ Mn) By Treatment, 2013-2017
7.4.1. Drugs
7.4.1.1. Oral
7.4.1.1.1. Rx
7.4.1.1.2. OTC
7.4.1.2. Topical
7.4.1.2.1. Rx
7.4.1.2.2. OTC
7.4.2. Lasers
7.4.2.1. Neodymium: yttrium-aluminum-garnet laser (Nd:YAG)
7.4.2.2. Dual-wavelength near-infrared laser
7.4.2.3. CO2 Ablative Laser
7.4.3. Photodynamic Therapy
7.5. Market Size (US$ Mn) Forecast By Treatment Type, 2018-2028
7.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2017
7.6.1. Distal Subungual Onychomycosis
7.6.2. White Superficial Onychomycosis
7.6.3. Proximal Subungual Onychomycosis
7.6.4. Candidal Onychomycosis
7.6.5. Total Dystrophic Onychomycosis
7.7. Market Size (US$ Mn) Forecast By Indication, 2018-2028
7.8. Historical Market Size (US$ Mn) Trend Analysis By Gender, 2013-2017
7.8.1. Male
7.8.2. Female
7.9. Market Size (US$ Mn) Forecast By Gender, 2018-2028
7.10. Historical Market Size (US$ Mn) Trend Analysis By Age Group, 2013-2017
7.10.1. 0-18 Years
7.10.2. 18-39 Years
7.10.3. 40-64 Years
7.10.4. 65 Years and Above
7.11. Market Size (US$ Mn) Forecast By Age Group, 2018-2028
7.12. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
7.12.1. Institutional Sales
7.12.1.1. Hospitals
7.12.1.2. Dermatology Clinics
7.12.2. Retail Sales
7.12.2.1. Retail Pharmacies
7.12.2.2. Drugs Stores
7.12.2.3. Mail Order Pharmacies & Online Sales
7.13. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028
7.14. Market Attractiveness Analysis
7.14.1. By Country
7.14.2. By Treatment
7.14.3. By Indication
7.14.4. By Gender
7.14.5. By Age Group
7.14.6. By Distribution Channel
7.15. Drivers and Restraints: Impact Analysis
7.16. Key Market Participants – Intensity Mapping

8. Latin America Onychomycosis Treatment Market Analysis 2013–2017 and Forecast 2018–2028
8.1. Introduction
8.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Argentina
8.2.4. Rest of Latin America
8.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
8.4. Historical Market Size (US$ Mn) By Treatment, 2013-2017
8.4.1. Drugs
8.4.1.1. Oral
8.4.1.1.1. Rx
8.4.1.1.2. OTC
8.4.1.2. Topical
8.4.1.2.1. Rx
8.4.1.2.2. OTC
8.4.2. Lasers
8.4.2.1. Neodymium: yttrium-aluminum-garnet laser (Nd:YAG)
8.4.2.2. Dual-wavelength near-infrared laser
8.4.2.3. CO2 Ablative Laser
8.4.3. Photodynamic Therapy
8.5. Market Size (US$ Mn) Forecast By Treatment Type, 2018-2028
8.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2017
8.6.1. Distal Subungual Onychomycosis
8.6.2. White Superficial Onychomycosis
8.6.3. Proximal Subungual Onychomycosis
8.6.4. Candidal Onychomycosis
8.6.5. Total Dystrophic Onychomycosis
8.7. Market Size (US$ Mn) Forecast By Indication, 2018-2028
8.8. Historical Market Size (US$ Mn) Trend Analysis By Gender, 2013-2017
8.8.1. Male
8.8.2. Female
8.9. Market Size (US$ Mn) Forecast By Gender, 2018-2028
8.10. Historical Market Size (US$ Mn) Trend Analysis By Age Group, 2013-2017
8.10.1. 0-18 Years
8.10.2. 18-39 Years
8.10.3. 40-64 Years
8.10.4. 65 Years and Above
8.11. Market Size (US$ Mn) Forecast By Age Group, 2018-2028
8.12. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
8.12.1. Institutional Sales
8.12.1.1. Hospitals
8.12.1.2. Dermatology Clinics
8.12.2. Retail Sales
8.12.2.1. Retail Pharmacies
8.12.2.2. Drugs Stores
8.12.2.3. Mail Order Pharmacies & Online Sales
8.13. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028
8.14. Market Attractiveness Analysis
8.14.1. By Country
8.14.2. By Treatment
8.14.3. By Indication
8.14.4. By Gender
8.14.5. By Age Group
8.14.6. By Distribution Channel
8.15. Drivers and Restraints: Impact Analysis
8.16. Key Market Participants – Intensity Mapping

9. Western Europe Onychomycosis Treatment Market Analysis 2013–2017 and Forecast 2018–2028
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
9.2.1. Germany
9.2.2. U.K
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Nordics
9.2.7. Benelux
9.2.8. Rest of Western Europe
9.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
9.4. Historical Market Size (US$ Mn) By Treatment, 2013-2017
9.4.1. Drugs
9.4.1.1. Oral
9.4.1.1.1. Rx
9.4.1.1.2. OTC
9.4.1.2. Topical
9.4.1.2.1. Rx
9.4.1.2.2. OTC
9.4.2. Lasers
9.4.2.1. Neodymium: yttrium-aluminum-garnet laser (Nd:YAG)
9.4.2.2. Dual-wavelength near-infrared laser
9.4.2.3. CO2 Ablative Laser
9.4.3. Photodynamic Therapy
9.5. Market Size (US$ Mn) Forecast By Treatment Type, 2018-2028
9.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2017
9.6.1. Distal Subungual Onychomycosis
9.6.2. White Superficial Onychomycosis
9.6.3. Proximal Subungual Onychomycosis
9.6.4. Candidal Onychomycosis
9.6.5. Total Dystrophic Onychomycosis
9.7. Market Size (US$ Mn) Forecast By Indication, 2018-2028
9.8. Historical Market Size (US$ Mn) Trend Analysis By Gender, 2013-2017
9.8.1. Male
9.8.2. Female
9.9. Market Size (US$ Mn) Forecast By Gender, 2018-2028
9.10. Historical Market Size (US$ Mn) Trend Analysis By Age Group, 2013-2017
9.10.1. 0-18 Years
9.10.2. 18-39 Years
9.10.3. 40-64 Years
9.10.4. 65 Years and Above
9.11. Market Size (US$ Mn) Forecast By Age Group, 2018-2028
9.12. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
9.12.1. Institutional Sales
9.12.1.1. Hospitals
9.12.1.2. Dermatology Clinics
9.12.2. Retail Sales
9.12.2.1. Retail Pharmacies
9.12.2.2. Drugs Stores
9.12.2.3. Mail Order Pharmacies & Online Sales
9.13. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028
9.14. Market Attractiveness Analysis
9.14.1. By Country
9.14.2. By Treatment
9.14.3. By Indication
9.14.4. By Gender
9.14.5. By Age Group
9.14.6. By Distribution Channel
9.15. Drivers and Restraints: Impact Analysis
9.16. Key Market Participants – Intensity Mapping

10. Eastern Europe Onychomycosis Treatment Market Analysis 2013–2017 and Forecast 2018–2028
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
10.2.1. Russia
10.2.2. Poland
10.2.3. Rest of Eastern Europe
10.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
10.4. Historical Market Size (US$ Mn) By Treatment, 2013-2017
10.4.1. Drugs
10.4.1.1. Oral
10.4.1.1.1. Rx
10.4.1.1.2. OTC
10.4.1.2. Topical
10.4.1.2.1. Rx
10.4.1.2.2. OTC
10.4.2. Lasers
10.4.2.1. Neodymium: yttrium-aluminum-garnet laser (Nd:YAG)
10.4.2.2. Dual-wavelength near-infrared laser
10.4.2.3. CO2 Ablative Laser
10.4.3. Photodynamic Therapy
10.5. Market Size (US$ Mn) Forecast By Treatment Type, 2018-2028
10.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2017
10.6.1. Distal Subungual Onychomycosis
10.6.2. White Superficial Onychomycosis
10.6.3. Proximal Subungual Onychomycosis
10.6.4. Candidal Onychomycosis
10.6.5. Total Dystrophic Onychomycosis
10.7. Market Size (US$ Mn) Forecast By Indication, 2018-2028
10.8. Historical Market Size (US$ Mn) Trend Analysis By Gender, 2013-2017
10.8.1. Male
10.8.2. Female
10.9. Market Size (US$ Mn) Forecast By Gender, 2018-2028
10.10. Historical Market Size (US$ Mn) Trend Analysis By Age Group, 2013-2017
10.10.1. 0-18 Years
10.10.2. 18-39 Years
10.10.3. 40-64 Years
10.10.4. 65 Years and Above
10.11. Market Size (US$ Mn) Forecast By Age Group, 2018-2028
10.12. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
10.12.1. Institutional Sales
10.12.1.1. Hospitals
10.12.1.2. Dermatology Clinics
10.12.2. Retail Sales
10.12.2.1. Retail Pharmacies
10.12.2.2. Drugs Stores
10.12.2.3. Mail Order Pharmacies & Online Sales
10.13. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028
10.14. Market Attractiveness Analysis
10.14.1. By Country
10.14.2. By Treatment
10.14.3. By Indication
10.14.4. By Gender
10.14.5. By Age Group
10.14.6. By Distribution Channel
10.15. Drivers and Restraints: Impact Analysis
10.16. Key Market Participants – Intensity Mapping

11. Asia Pacific Excluding China & Japan Onychomycosis Treatment Market Analysis 2013–2017 and Forecast 2018–2028
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
11.2.1. India
11.2.2. Australia and New Zealand
11.2.3. ASEAN
11.2.4. Rest of APECJ
11.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
11.4. Historical Market Size (US$ Mn) By Treatment, 2013-2017
11.4.1. Drugs
11.4.1.1. Oral
11.4.1.1.1. Rx
11.4.1.1.2. OTC
11.4.1.2. Topical
11.4.1.2.1. Rx
11.4.1.2.2. OTC
11.4.2. Lasers
11.4.2.1. Neodymium: yttrium-aluminum-garnet laser (Nd:YAG)
11.4.2.2. Dual-wavelength near-infrared laser
11.4.2.3. CO2 Ablative Laser
11.4.3. Photodynamic Therapy
11.5. Market Size (US$ Mn) Forecast By Treatment Type, 2018-2028
11.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2017
11.6.1. Distal Subungual Onychomycosis
11.6.2. White Superficial Onychomycosis
11.6.3. Proximal Subungual Onychomycosis
11.6.4. Candidal Onychomycosis
11.6.5. Total Dystrophic Onychomycosis
11.7. Market Size (US$ Mn) Forecast By Indication, 2018-2028
11.8. Historical Market Size (US$ Mn) Trend Analysis By Gender, 2013-2017
11.8.1. Male
11.8.2. Female
11.9. Market Size (US$ Mn) Forecast By Gender, 2018-2028
11.10. Historical Market Size (US$ Mn) Trend Analysis By Age Group, 2013-2017
11.10.1. 0-18 Years
11.10.2. 18-39 Years
11.10.3. 40-64 Years
11.10.4. 65 Years and Above
11.11. Market Size (US$ Mn) Forecast By Age Group, 2018-2028
11.12. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
11.12.1. Institutional Sales
11.12.1.1. Hospitals
11.12.1.2. Dermatology Clinics
11.12.2. Retail Sales
11.12.2.1. Retail Pharmacies
11.12.2.2. Drugs Stores
11.12.2.3. Mail Order Pharmacies & Online Sales
11.13. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028
11.14. Market Attractiveness Analysis
11.14.1. By Country
11.14.2. By Treatment
11.14.3. By Indication
11.14.4. By Gender
11.14.5. By Age Group
11.14.6. By Distribution Channel
11.15. Drivers and Restraints: Impact Analysis
11.16. Key Market Participants – Intensity Mapping

12. China Onychomycosis Treatment Market Analysis 2013–2017 and Forecast 2018–2028
12.1. Introduction
12.2. Historical Market Size (US$ Mn) By Treatment, 2013-2017
12.2.1. Drugs
12.2.1.1. Oral
12.2.1.1.1. Rx
12.2.1.1.2. OTC
12.2.1.2. Topical
12.2.1.2.1. Rx
12.2.1.2.2. OTC
12.2.2. Lasers
12.2.2.1. Neodymium: yttrium-aluminum-garnet laser (Nd:YAG)
12.2.2.2. Dual-wavelength near-infrared laser
12.2.2.3. CO2 Ablative Laser
12.2.3. Photodynamic Therapy
12.3. Market Size (US$ Mn) Forecast By Treatment Type, 2018-2028
12.4. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2017
12.4.1. Distal Subungual Onychomycosis
12.4.2. White Superficial Onychomycosis
12.4.3. Proximal Subungual Onychomycosis
12.4.4. Candidal Onychomycosis
12.4.5. Total Dystrophic Onychomycosis
12.5. Market Size (US$ Mn) Forecast By Indication, 2018-2028
12.6. Historical Market Size (US$ Mn) Trend Analysis By Gender, 2013-2017
12.6.1. Male
12.6.2. Female
12.7. Market Size (US$ Mn) Forecast By Gender, 2018-2028
12.8. Historical Market Size (US$ Mn) Trend Analysis By Age Group, 2013-2017
12.8.1. 0-18 Years
12.8.2. 18-39 Years
12.8.3. 40-64 Years
12.8.4. 65 Years and Above
12.9. Market Size (US$ Mn) Forecast By Age Group, 2018-2028
12.10. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
12.10.1. Institutional Sales
12.10.1.1. Hospitals
12.10.1.2. Dermatology Clinics
12.10.2. Retail Sales
12.10.2.1. Retail Pharmacies
12.10.2.2. Drugs Stores
12.10.2.3. Mail Order Pharmacies & Online Sales
12.11. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028
12.12. Market Attractiveness Analysis
12.12.1. By Country
12.12.2. By Treatment
12.12.3. By Indication
12.12.4. By Gender
12.12.5. By Age Group
12.12.6. By Distribution Channel
12.13. Drivers and Restraints: Impact Analysis
12.14. Key Market Participants – Intensity Mapping

13. Japan Onychomycosis Treatment Market Analysis 2013–2017 and Forecast 2018–2028
13.1. Introduction
13.2. Historical Market Size (US$ Mn) By Treatment, 2013-2017
13.2.1. Drugs
13.2.1.1. Oral
13.2.1.1.1. Rx
13.2.1.1.2. OTC
13.2.1.2. Topical
13.2.1.2.1. Rx
13.2.1.2.2. OTC
13.2.2. Lasers
13.2.2.1. Neodymium: yttrium-aluminum-garnet laser (Nd:YAG)
13.2.2.2. Dual-wavelength near-infrared laser
13.2.2.3. CO2 Ablative Laser
13.2.3. Photodynamic Therapy
13.3. Market Size (US$ Mn) Forecast By Treatment Type, 2018-2028
13.4. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2017
13.4.1. Distal Subungual Onychomycosis
13.4.2. White Superficial Onychomycosis
13.4.3. Proximal Subungual Onychomycosis
13.4.4. Candidal Onychomycosis
13.4.5. Total Dystrophic Onychomycosis
13.5. Market Size (US$ Mn) Forecast By Indication, 2018-2028
13.6. Historical Market Size (US$ Mn) Trend Analysis By Gender, 2013-2017
13.6.1. Male
13.6.2. Female
13.7. Market Size (US$ Mn) Forecast By Gender, 2018-2028
13.8. Historical Market Size (US$ Mn) Trend Analysis By Age Group, 2013-2017
13.8.1. 0-18 Years
13.8.2. 18-39 Years
13.8.3. 40-64 Years
13.8.4. 65 Years and Above
13.9. Market Size (US$ Mn) Forecast By Age Group, 2018-2028
13.10. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
13.10.1. Institutional Sales
13.10.1.1. Hospitals
13.10.1.2. Dermatology Clinics
13.10.2. Retail Sales
13.10.2.1. Retail Pharmacies
13.10.2.2. Drugs Stores
13.10.2.3. Mail Order Pharmacies & Online Sales
13.11. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028
13.12. Market Attractiveness Analysis
13.12.1. By Country
13.12.2. By Treatment
13.12.3. By Indication
13.12.4. By Gender
13.12.5. By Age Group
13.12.6. By Distribution Channel
13.13. Drivers and Restraints: Impact Analysis
13.14. Key Market Participants – Intensity Mapping

14. Middle East and Africa Onychomycosis Treatment Market Analysis 2013–2017 and Forecast 2018–2028
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
14.2.1. GCC Countries
14.2.2. South Africa
14.2.3. Rest of Middle East and Africa
14.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
14.4. Historical Market Size (US$ Mn) By Treatment, 2013-2017
14.4.1. Drugs
14.4.1.1. Oral
14.4.1.1.1. Rx
14.4.1.1.2. OTC
14.4.1.2. Topical
14.4.1.2.1. Rx
14.4.1.2.2. OTC
14.4.2. Lasers
14.4.2.1. Neodymium: yttrium-aluminum-garnet laser (Nd:YAG)
14.4.2.2. Dual-wavelength near-infrared laser
14.4.2.3. CO2 Ablative Laser
14.4.3. Photodynamic Therapy
14.5. Market Size (US$ Mn) Forecast By Treatment Type, 2018-2028
14.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2017
14.6.1. Distal Subungual Onychomycosis
14.6.2. White Superficial Onychomycosis
14.6.3. Proximal Subungual Onychomycosis
14.6.4. Candidal Onychomycosis
14.6.5. Total Dystrophic Onychomycosis
14.7. Market Size (US$ Mn) Forecast By Indication, 2018-2028
14.8. Historical Market Size (US$ Mn) Trend Analysis By Gender, 2013-2017
14.8.1. Male
14.8.2. Female
14.9. Market Size (US$ Mn) Forecast By Gender, 2018-2028
14.10. Historical Market Size (US$ Mn) Trend Analysis By Age Group, 2013-2017
14.10.1. 0-18 Years
14.10.2. 18-39 Years
14.10.3. 40-64 Years
14.10.4. 65 Years and Above
14.11. Market Size (US$ Mn) Forecast By Age Group, 2018-2028
14.12. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
14.12.1. Institutional Sales
14.12.1.1. Hospitals
14.12.1.2. Dermatology Clinics
14.12.2. Retail Sales
14.12.2.1. Retail Pharmacies
14.12.2.2. Drugs Stores
14.12.2.3. Mail Order Pharmacies & Online Sales
14.13. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028
14.14. Market Attractiveness Analysis
14.14.1. By Country
14.14.2. By Treatment
14.14.3. By Indication
14.14.4. By Gender
14.14.5. By Age Group
14.14.6. By Distribution Channel
14.15. Drivers and Restraints: Impact Analysis
14.16. Key Market Participants – Intensity Mapping

15. Forecast Factors: Relevance and Impact

16. Forecast Assumptions

17. Market Structure Analysis

17.1. Parent Market Analysis
17.2. Market Structure by Tier
17.3. Market Share Analysis (2017)

18. Competition Analysis
18.1. Competition Dashboard
18.2. Competitors Deep Dive
18.2.1. Valeant Pharmaceuticals Inc.
18.2.1.1. Overview
18.2.1.2. Analyst Commentary
18.2.1.3. Key Financials
18.2.1.4. Key Developments
18.2.2. Galderma S.A.
18.2.3. Novartis AG
18.2.4. Pfizer, Inc.
18.2.5. Moberg Pharma AB
18.2.6. Johnson & Johnson Services, Inc.
18.2.7. Bayer AG
18.2.8. Dr. Reddy’s Laboratories Ltd.
18.2.9. Cipla Ltd.
18.2.10. Medimetriks Pharmaceuticals, Inc.
18.2.11. Lumenis Ltd.
18.2.12. Biofrontera AG
18.2.13. Leo Pharma A/S

19. Global Onychomycosis Treatment Market Analysis 2013–2017 and Forecast 2018–2028 By Region
19.1. Introduction / Key Findings
19.2. Historical Market Size (US$ Mn) Analysis By Region
19.2.1. North America
19.2.2. Latin America
19.2.3. Western Europe
19.2.4. Eastern Europe
19.2.5. Asia Pacific Excluding Japan And China
19.2.6. China
19.2.7. Japan
19.2.8. Middle East and Africa
19.3. Market Size (US$ Mn) Forecast By Region
19.4. Market Attractiveness Analysis By Region

20. Global Onychomycosis Treatment Market Analysis 2013–2017 and Forecast 2018–2028, By Treatment
20.1. Introduction/Key Finding
20.2. Historical Market Size (US$ Mn) Analysis By Treatment, 2013-2017
20.2.1. Drugs
20.2.1.1. Oral
20.2.1.1.1. Rx
20.2.1.1.2. OTC
20.2.1.2. Topical
20.2.1.2.1. Rx
20.2.1.2.2. OTC
20.2.2. Lasers
20.2.2.1. Neodymium: yttrium-aluminum-garnet laser (Nd:YAG)
20.2.2.2. Dual-wavelength near-infrared laser
20.2.2.3. CO2 Ablative Laser
20.2.3. Photodynamic Therapy
20.3. Market Size (US$ Mn) Forecast By Treatment, 2018-2028
20.4. Market Attractiveness Analysis By Treatment

21. Global Onychomycosis Treatment Market Analysis 2013–2017 and Forecast 2018–2028, By Indication
21.1. Introduction/Key Finding
21.2. Historical Market Size (US$ Mn) Analysis By Indication, 2013-2017
21.2.1. Distal Subungual Onychomycosis
21.2.2. White Superficial Onychomycosis
21.2.3. Proximal Subungual Onychomycosis
21.2.4. Candidal Onychomycosis
21.2.5. Total Dystrophic Onychomycosis
21.3. Market Size (US$ Mn) Forecast By Indication, 2018-2028
21.4. Market Attractiveness Analysis By Indication

22. Global Onychomycosis Treatment Market Analysis 2013–2017 and Forecast 2018–2028, By Gender
22.1. Introduction/Key Finding
22.2. Historical Market Size (US$ Mn) Analysis By Gender, 2013-2017
22.2.1. Male
22.2.2. Female
22.3. Market Size (US$ Mn) Forecast By Gender, 2018-2028
22.4. Market Attractiveness Analysis By Gender

23. Global Onychomycosis Treatment Market Analysis 2013–2017 and Forecast 2018–2028, By Age Group
23.1. Introduction/Key Finding
23.2. Historical Market Size (US$ Mn) Analysis By Age Group, 2013-2017
23.2.1. 0-18 Years
23.2.2. 18-39 Years
23.2.3. 40-64 Years
23.2.4. 65 Years and Above
23.3. Market Size (US$ Mn) Forecast By Age Group, 2018-2028
23.4. Market Attractiveness Analysis By Age Group

24. Global Onychomycosis Treatment Market Analysis 2013–2017 and Forecast 2018–2028, By End User
24.1. Introduction/Key Finding
24.2. Historical Market Size (US$ Mn) Analysis By End User, 2013-2017
24.2.1. Institutional Sales
24.2.1.1. Hospitals
24.2.1.2. Dermatology Clinics
24.2.2. Retail Sales
24.2.2.1. Retail Pharmacies
24.2.2.2. Drugs Stores
24.2.2.3. Mail Order Pharmacies & Online Sales
24.3. Market Size (US$ Mn) Forecast By End User, 2018-2028
24.4. Market Attractiveness Analysis By End User

25. Global Onychomycosis Treatment Market Analysis 2013–2017 and Forecast 2018–2028
25.1. Market Value Share Analysis By All Segment
25.2. Market Volume Share Analysis By Radionuclide Type
25.3. Y-o-Y Growth Analysis By All Segment
25.4. Absolute $ Opportunity

26. Assumptions and Acronyms Used

27. Research Methodology

List of Table

List of Tables

Table 01: Product Pipeline Analysis for Onychomycosis
Table 03: Reimbursement Analysis for Onychomycosis 
Table 03: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 04: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 05: North America Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 06: North America Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment
Table 07: North America Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication
Table 08: North America Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Gender
Table 09: North America Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Age Group
Table 10: North America Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
Table 11: Latin America Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 12: Latin America Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment
Table 13: Latin America Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication
Table 14: Latin America Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Gender
Table 15: Latin America Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Age Group
Table 16: Latin America Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
Table 17: Western Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 18: Western Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment
Table 19: Western Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication
Table 20: Western Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Gender
Table 21: Western Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Age Group
Table 22: Western Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
Table 23: Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 24: Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment
Table 25: Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication
Table 26: Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Gender
Table 27: Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Age Group
Table 28: Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
Table 29: Asia Pacific Excluding China & Japan Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 30: Asia Pacific Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment
Table 31: Asia Pacific Excluding China & Japan Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication
Table 32: Asia Pacific Excluding China & Japan Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Gender
Table 33: Asia Pacific Excluding China & Japan Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Age Group
Table 34: Asia Pacific Excluding China & Japan Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
Table 35: China Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment
Table 36: China Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication
Table 37: China Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Gender
Table 38: China Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Age Group
Table 39: China Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
Table 40: Japan Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment
Table 41: Japan Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication
Table 42: Japan Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Gender
Table 43: Japan Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Age Group
Table 44: Japan Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
Table 45: MEA Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 46: Middle East and Africa Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment
Table 47: MEA Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication
Table 48: MEA Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Gender
Table 49: MEA Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Age Group
Table 50: MEA Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
Table 51: Onychomycosis Treatment Market Value (US$ Mn) 2013–2017 and Forecast 2018-2026 By Region
Table 52: Global Onychomycosis Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment 
Table 53: Onychomycosis Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Indication
Table 54: Onychomycosis Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Gender
Table 55: Global Onychomycosis Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Age Group
Table 56: Middle East & Africa Onychomycosis Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User

List of Chart

List of Figures

Figure 01: Global Onychomycosis Treatment Market Value Share By Treatment (2018 E)
Figure 02: Global Onychomycosis Treatment Market Value Share By Indication (2018 E)
Figure 03: Global Onychomycosis Treatment Market Value Share By Gender(2018 E)
Figure 04: Global Onychomycosis Treatment Market Value Share By Age Group (2018 E)
Figure 05: Global Onychomycosis Treatment Market Value Share By End User(2018 E)
Figure 06: Global Onychomycosis Treatment Market Value Share By Region (2018 E)
Figure 07: GDP (US$ Trillion) and Healthcare Expenditure % (2017)
Figure 08: Net National income, Income Growth and Employment (2014)
Figure 09: Onychomycosis Incidence by Income Group (2017)
Figure 10: Onychomycosis Rate by Age Group (2017)
Figure 11: Pipeline Analysis for Onychomycosis, By Phase
Figure 12: Number of Clinical Trials for Onychomycosis, By Study Type
Figure 13: Global Healthcare Expenditure in US$ Tn (2013–2020)
Figure 14: North America Onychomycosis Treatment Market Share, By Country (2018E)
Figure 15: North America Onychomycosis Treatment Market Share, By Treatment (2018E)
Figure 16: North America Onychomycosis Treatment Market Share, By Indication (2018E)
Figure 17: North America Onychomycosis Treatment Market Share, By Gender (2018E)
Figure 18: North America Onychomycosis Treatment Market Share, By Age Group (2018E)
Figure 19: North America Onychomycosis Treatment Market Share, By End Users (2018E)
Figure 20: North America Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 21: North America Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 22: U.S. Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 23: U.S. Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 24: Canada Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 25: Canada Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 26: North America Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Drugs 
Figure 27: North America Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Drugs
Figure 28: North America Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Lasers 
Figure 29: North America Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Lasers 
Figure 30: North America Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy 
Figure 31: North America Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy 
Figure 32: North America Onychomycosis Treatment Market Attractiveness Analysis, By Country , 2018-2028
Figure 33: North America Onychomycosis Treatment Market Attractiveness Analysis, By Treatment, 2018-2028
Figure 34: North America Onychomycosis Treatment Market Attractiveness Analysis, By Indication, 2018-2028
Figure 35: North America Onychomycosis Treatment Market Attractiveness Analysis, By Gender, 2018-2028
Figure 36: North America Onychomycosis Treatment Market Attractiveness Analysis, By Age Group, 2018-2028
Figure 37: North America Onychomycosis Treatment Market Attractiveness Analysis, By End User, 2018-2028
Figure 38: Latin America Onychomycosis Treatment Market Share, By Country (2018E)
Figure 39: Latin America Onychomycosis Treatment Market Share, By Treatment (2018E)
Figure 40: Latin America Onychomycosis Treatment Market Share, By Indication (2018E)
Figure 41: Latin America Onychomycosis Treatment Market Share, By Gender (2018E)
Figure 42: Latin America Onychomycosis Treatment Market Share, By Age Group (2018E)
Figure 43: Latin America Onychomycosis Treatment Market Share, By End Users (2018E)
Figure 44: Latin America Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 45: Latin America Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 46: Brazil Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 47: Brazil Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 48: Mexico Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 49: Mexico Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 50: Argentina Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 51: Argentina Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 52: Rest of Latin America Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 53: Rest of Latin America Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 54: Latin America Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Drugs 
Figure 55: Latin America Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Drugs
Figure 56: Latin America Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Lasers 
Figure 57: Latin America Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Lasers 
Figure 58: Latin America Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy 
Figure 59: Latin America Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy 
Figure 60: Latin America Onychomycosis Treatment Market Attractiveness Analysis, By Country , 2018-2028
Figure 61: Latin America Onychomycosis Treatment Market Attractiveness Analysis, By Treatment, 2018-2028
Figure 62: Latin America Onychomycosis Treatment Market Attractiveness Analysis, By Indication, 2018-2028
Figure 63: Latin America Onychomycosis Treatment Market Attractiveness Analysis, By Gender, 2018-2028
Figure 64: Latin America Onychomycosis Treatment Market Attractiveness Analysis, By Age Group, 2018-2028
Figure 65: Latin America Onychomycosis Treatment Market Attractiveness Analysis, By End User, 2018-2028
Figure 66: Western Europe Onychomycosis Treatment Market Share, By Country (2018E)
Figure 67: Western Europe Onychomycosis Treatment Market Share, By Treatment (2018E)
Figure 68: Western Europe Onychomycosis Treatment Market Share, By Indication (2018E)
Figure 69: Western Europe Onychomycosis Treatment Market Share, By Gender (2018E)
Figure 70: Western Europe Onychomycosis Treatment Market Share, By Age Group (2018E)
Figure 71: Western Europe Onychomycosis Treatment Market Share, By End Users (2018E)
Figure 72: Western Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 73: Western Europe Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 74: Germany Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 75: Germany Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 76: France Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 77: France Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 78: Italy Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 79: Italy Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 80: Spain Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 81: Spain Europe Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 82: U.K. Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 83: U.K Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 84: Benelux Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 85: Benelux Europe Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 86: Nordics Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 87: Nordics Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 88: Rest of Western Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 89: Rest of Western Europe Onychomycosis Treatment Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 90: Western Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Drugs 
Figure 91: Western Europe Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Drugs
Figure 92: Western Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Lasers 
Figure 93: Western Europe Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Lasers 
Figure 94: Western Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy 
Figure 95: Western Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy 
Figure 96: Western Europe Onychomycosis Treatment Market Attractiveness Analysis, By Country , 2018-2028
Figure 97: Western Europe Onychomycosis Treatment Market Attractiveness Analysis, By Treatment, 2018-2028
Figure 98: Western Europe Onychomycosis Treatment Market Attractiveness Analysis, By Indication, 2018-2028
Figure 99: Western Europe Onychomycosis Treatment Market Attractiveness Analysis, By Gender, 2018-2028
Figure 100: Western Europe Onychomycosis Treatment Market Attractiveness Analysis, By Age Group, 2018-2028
Figure 101: Western Europe Onychomycosis Treatment Market Attractiveness Analysis, By End User, 2018-2028
Figure 102: Eastern Europe Onychomycosis Treatment Market Share, By Country (2018E)
Figure 103: Eastern Europe Onychomycosis Treatment Market Share, By Treatment (2018E)
Figure 104: Eastern Europe Onychomycosis Treatment Market Share, By Indication (2018E)
Figure 105: Eastern Europe Onychomycosis Treatment Market Share, By Gender (2018E)
Figure 106: Eastern Europe Onychomycosis Treatment Market Share, By Age Group (2018E)
Figure 107: Eastern Europe Onychomycosis Treatment Market Share, By End Users (2018E)
Figure 108: Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 109: Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 110: Russia Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 111: Russia Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 112: Poland Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 113: Poland Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 114: Rest of Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 115: Rest of Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 116: Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Drugs 
Figure 117: Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Drugs
Figure 118: Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Lasers 
Figure 119: Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Lasers 
Figure 120: Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy 
Figure 121: Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy 
Figure 122: Eastern Europe Onychomycosis Treatment Market Attractiveness Analysis, By Country , 2018-2028
Figure 123: Eastern Europe Onychomycosis Treatment Market Attractiveness Analysis, By Treatment, 2018-2028
Figure 124: Eastern Europe Onychomycosis Treatment Market Attractiveness Analysis, By Indication, 2018-2028
Figure 125: Eastern Europe Onychomycosis Treatment Market Attractiveness Analysis, By Gender, 2018-2028
Figure 126: Eastern Europe Onychomycosis Treatment Market Attractiveness Analysis, By Age Group, 2018-2028
Figure 127: Eastern Europe Onychomycosis Treatment Market Attractiveness Analysis, By End User, 2018-2028
Figure 128: Asia Pacific Excluding China & Japan Onychomycosis Treatment Market Share, By Country (2018E)
Figure 129: Asia Pacific Excluding China & Japan Onychomycosis Treatment Market Share, By Treatment (2018E)
Figure 130: Asia Pacific Excluding China & Japan Onychomycosis Treatment Market Share, By Indication (2018E)
Figure 131: Asia Pacific Excluding China & Japan Onychomycosis Treatment Market Share, By Gender (2018E)
Figure 132: Asia Pacific Excluding China & Japan Onychomycosis Treatment Market Share, By Age Group (2018E)
Figure 133: Asia Pacific Excluding China & Japan Onychomycosis Treatment Market Share, By End Users (2018E)
Figure 134: APECJ Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 135: APECJ Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 136: India Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 137: India Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 138: ASEAN Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 139: ASEAN Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 140: Australia & New Zealand Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 141: Australia & New Zealand Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 142: Rest of APECJ Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 143: Rest of APECJ Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 144: APECJ Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Drugs 
Figure 145: APECJ Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Drugs
Figure 146: APECJ pan Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Lasers 
Figure 147: APECJ n Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Lasers 
Figure 148: APECJ Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy 
Figure 149: APECJ Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy 
Figure 150: APECJ Onychomycosis Treatment Market Attractiveness Analysis, By Country , 2018-2028
Figure 151: APECJ Onychomycosis Treatment Market Attractiveness Analysis, By Treatment, 2018-2028
Figure 152: APECJ Onychomycosis Treatment Market Attractiveness Analysis, By Indication, 2018-2028
Figure 153: APECJ Onychomycosis Treatment Market Attractiveness Analysis, By Gender, 2018-2028
Figure 154: APECJ Onychomycosis Treatment Market Attractiveness Analysis, By Age Group, 2018-2028
Figure 155: APECJ Onychomycosis Treatment Market Attractiveness Analysis, By End User, 2018-2028
Figure 156: China Onychomycosis Treatment Market Share, By Gender (2018E)
Figure 157: China Onychomycosis Treatment Market Share, By Treatment (2018E)
Figure 158: China Onychomycosis Treatment Market Share, By Indication (2018E)
Figure 159: China Onychomycosis Treatment Market Share, By Age Group (2018E)
Figure 160: China Onychomycosis Treatment Market Share, By End Users (2018E)
Figure 161: China Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 162: China Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 163: China Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Drugs 
Figure 164: China Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Drugs
Figure 165: China Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Lasers 
Figure 166: China Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Lasers 
Figure 167: China Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy 
Figure 168: China Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy 
Figure 169: China Onychomycosis Treatment Market Attractiveness Analysis, By Gender, 2018-2028
Figure 170: China Onychomycosis Treatment Market Attractiveness Analysis, By Treatment, 2018-2028
Figure 171: China Onychomycosis Treatment Market Attractiveness Analysis, By Indication, 2018-2028
Figure 172: China Onychomycosis Treatment Market Attractiveness Analysis, By Age Group, 2018-2028
Figure 173: China Onychomycosis Treatment Market Attractiveness Analysis, By End User, 2018-2028
Figure 174: Japan Onychomycosis Treatment Market Share, By Gender (2018E)
Figure 175: Japan Onychomycosis Treatment Market Share, By Treatment (2018E)
Figure 176: Japan Onychomycosis Treatment Market Share, By Indication (2018E)
Figure 177: Japan Onychomycosis Treatment Market Share, By Age Group (2018E)
Figure 178: Japan Onychomycosis Treatment Market Share, By End Users (2018E)
Figure 179: Japan Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 180: Japan Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 181: Japan Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Drugs 
Figure 182: Japan Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Drugs
Figure 183: Japan Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Lasers 
Figure 184: Japan Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Lasers 
Figure 185: Japan Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy 
Figure 186: Japan Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy 
Figure 187: Japan Onychomycosis Treatment Market Attractiveness Analysis, By Gender, 2018-2028
Figure 188: Japan Onychomycosis Treatment Market Attractiveness Analysis, By Treatment, 2018-2028
Figure 189: Japan Onychomycosis Treatment Market Attractiveness Analysis, By Indication, 2018-2028
Figure 190: Japan Onychomycosis Treatment Market Attractiveness Analysis, By Age Group, 2018-2028
Figure 191: Japan Onychomycosis Treatment Market Attractiveness Analysis, By End User, 2018-2028
Figure 192: MEA Onychomycosis Treatment Market Share, By Country (2018E)
Figure 193: MEA Onychomycosis Treatment Market Share, By Treatment (2018E)
Figure 194: MEA Onychomycosis Treatment Market Share, By Indication (2018E)
Figure 195: MEA Onychomycosis Treatment Market Share, By Gender (2018E)
Figure 196: MEA Onychomycosis Treatment Market Share, By Age Group (2018E)
Figure 197: MEA Onychomycosis Treatment Market Share, By End Users (2018E)
Figure 198: MEA Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 199: MEA Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 200: GCC Countries Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 201: GCC Countries Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 202: South Africa Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 203: South Africa Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 204: Rest of MEA Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 205: Rest of MEA Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 206: MEA Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Drugs 
Figure 207: MEA Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Drugs
Figure 208: MEA Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Lasers 
Figure 209: MEA Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Lasers 
Figure 210: MEA Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy 
Figure 211: MEA Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy 
Figure 212: MEA Onychomycosis Treatment Market Attractiveness Analysis, By Country, 2018-2028
Figure 213: MEA Onychomycosis Treatment Market Attractiveness Analysis, By Treatment, 2018-2028
Figure 214: MEA Onychomycosis Treatment Market Attractiveness Analysis, By Indication, 2018-2028
Figure 215: MEA Onychomycosis Treatment Market Attractiveness Analysis, By Gender, 2018-2028
Figure 216: MEA Onychomycosis Treatment Market Attractiveness Analysis, By Age Group, 2018-2028
Figure 217: MEA Onychomycosis Treatment Market Attractiveness Analysis, By End User, 2018-2028
Figure 218: Global Onychomycosis Treatment Market 2017, Parent Market
Figure 219: Dermatophytic Onychomycosis Therapeutics Market: Company Share Analysis (2017)
Figure 220: Global Onychomycosis Treatment Market Share Analysis (%) By Region, 2018 & 2028
Figure 221: Global Onychomycosis Treatment Market Y-o-Y Growth (%) By Region, 2017–2028
Figure 222: Global Onychomycosis Treatment Market Attractiveness Analysis By Region, 2018–2028
Figure 223: Global Onychomycosis Treatment Market Share Analysis (%) By Treatment, 2018 & 2028
Figure 224: Global Onychomycosis Treatment Market Y-o-Y Growth (%) By Treatment, 2017–2028
Figure 225: Global Onychomycosis Treatment Market Attractiveness Analysis By Treatment, 2018–2028
Figure 226: Global Onychomycosis Treatment Market Share Analysis (%) By Indication, 2018 & 2028
Figure 227: Onychomycosis Treatment Market Y-o-Y Growth (%) By Indication, 2017–2028
Figure 228: Global Onychomycosis Treatment Market Attractiveness Analysis By Indication, 2018–2028
Figure 229: Global Onychomycosis Treatment Market Share Analysis (%) By Gender, 2018 & 2028
Figure 230: Onychomycosis Treatment Market Y-o-Y Growth (%) By Gender, 2017–2028
Figure 231: Global Onychomycosis Treatment Market Attractiveness Analysis By Gender, 2018–2028
Figure 232: Global Onychomycosis Treatment Market Share Analysis (%) By Age Group, 2018 & 2028
Figure 233: Global Onychomycosis Treatment Market Y-o-Y Growth (%) By Age Group, 2017–2028
Figure 234: Global Onychomycosis Treatment Market Attractiveness Analysis By Age Group, 2018–2028
Figure 235: Global Onychomycosis Treatment Market Share Analysis (%) By End User, 2018 & 2028
Figure 236: Onychomycosis Treatment Market Y-o-Y Growth (%) By End User, 2017–2028
Figure 237: Global Onychomycosis Treatment Market Attractiveness Analysis By End User, 2018–2028
Figure 238: Global Onychomycosis Treatment Market Value Analysis and Forecast, 2017–2026 (US$ Mn)
Figure 239: Global Onychomycosis Treatment Market Absolute $ Opportunity, 2013–2028

 

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *